|
|
|
| Clinical Observation with Lung Cancer Undergoing Shenqifuzheng Combined Themotherapy |
| LI Qingshan, BAI Lu, GAO Dongqi, et al |
| The Affiliated Hospital of Chengde Medical College, Hebei Chengde 067000, China |
|
|
|
|
Abstract Objective: To investigate the effects of Shenqifuzheng Injection on quality of life and immune function in patients with chemotherapy of lung cancer. Methods: We analyzed 74 cases of lung cancer patients randomly divided into treatment group (Shen Qi Fu Zheng group), positive control group (Addie injection group) and blank control group. Results: In terms of total effective rate, the treatment group was higher than the blank group, the difference was significant (P <|0.05). After treatment, the CD3+, CD4+, CD4+/CD8+and NK cells were no difference between the treatment group and the control group (P>0.05), While the control group after treatment, CD3, CD4+, CD8+, CD4+/CD8+ ratio were lower than before treatment (P<0.05 or P<0.01).After treatment, the CD3+, CD4+, CD4+/CD8+ ratio and the blank control group had statistical significance with the treatment group (P<0.05).Conclusion: Shen Qi Fu Zheng Injection combined with chemotherap can improve the curative effect and the immune function in the lung cancer patients.
|
|
|
|
|
|
[1] Parkin D,Bray F,et al.Global cancer statistics,2002[J].CA Cancer Clin, 2005,55:74~108.
[2] Jemal A,Siegel R,et al.Cancer statistics,2006[J].CA Cancer Clin;2006,56(2):106~130.
[3] Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014[J].CACancer Clin, 2014, 64(1): 9~29.
[4] Rivera Mp. Multimodality therapy in the treatment of lung cancer[J].Semin Respir Crit Care Med, 2004, 25 (2): 395~401.
[5] 刘志臻,余宗阳,等.肺泰胶囊维持治疗对中晚期非小细胞肺癌无进展生存期的影响[J].肿瘤学杂志,2009,4(4).344~346.
[6] 荀培,韩磊,赵丽波等.艾迪注射液辅助治疗晚期非小细胞肺癌的疗效观察[J].中国医院用药评价与分析,2016,16(9):1164~1166.
[7] 郭自强,朱陵群.党参对大鼠离体心脏缺血再灌注损伤的保护作用[J].北京中医药大学学报,1995,18(5):39~41.
[8] 沈克平,胡兵,薛海燕.黄芪注射液联合IL-2对胃癌术后化疗后患者免疫功能的影响[J].辽宁中医杂志,2010,(9):105~107. |
|
|
|
2017, Vol. 23 
